DERM — Journey Medical Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1867066 ·
Last close
$6.43
Market Cap
$142.90M
52W High
$9.56
52W Low
$4.31
ADV30
179,452
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 18,510,000 | 12,367,000 | 456,000 | -312,000 | 98,356,000 | 25,643,000 | 66,242,000 |
| Mar 2026 | 15,961,000 | 9,743,000 | -1,492,000 | -2,230,000 | 91,534,000 | 27,219,000 | 60,703,000 |
| Dec 2025 | 16,079,000 | 10,639,000 | -443,000 | -1,247,000 | 94,589,000 | 24,090,000 | 62,737,000 |
| Sep 2025 | 17,631,000 | 11,876,000 | -1,529,000 | -2,315,000 | 85,191,000 | 24,948,000 | 59,293,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,700,000
Investing CF
$-15,000,000
Financing CF
$12,849,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.51
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-100,688,000
Inventory
$9,292,000
Receivables
$24,992,000
ST Investments
—
EBIT TTM
$-5,829,000
Pretax Income TTM
$-9,528,000
Interest Exp TTM
$3,699,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$68,181,000
EBITDA
$1,216,000
Free Cash Flow
$-5,463,500
Enterprise Value
$203,960,368
Total Cash
$25,643,000
Total Debt
$25,541,000
Shares Out
22,224,395
Trailing EPS
$-0.22
Book Value
$1.16
ROE
-23.8%
ROA
-2.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 61,858,000 | -8,172,000 | -11,431,000 | 94,589,000 | 62,737,000 | 31,852,000 | -12,441,000 |
| Dec 2024 | 56,134,000 | -18,230,000 | -14,672,000 | 80,241,000 | 60,172,000 | 20,069,000 | -9,127,000 |
| Dec 2023 | 79,181,000 | 1,070,000 | -3,853,000 | 76,849,000 | 56,499,000 | 20,350,000 | 5,240,000 |
| Dec 2022 | 73,669,000 | -27,517,000 | -29,628,000 | 105,160,000 | 88,178,000 | 16,982,000 | -13,534,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.06
Max Pain — expiry 2027-02-19
max pain strike: $5.00 · spot: $6.43 · call oi: 1,111 · put oi: 2
Expected Move to 2027-02-19:
±$1.98
(30.72%) —
implied range
$4.45 –
$8.40
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RNA | Atrium Therapeutics, Inc. | $144.03M | $8.42 | — |
| KRRO | Korro Bio, Inc. | $140.04M | $9.51 | — |
| MENS | Jyong Biotech Ltd. | $146.24M | $1.97 | — |
| SPRB | SPRUCE BIOSCIENCES, INC. | $136.54M | $47.51 | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $133.84M | $6.92 | — |
News headlines (Yahoo Finance, 1h cache)
Are Options Traders Betting on a Big Move in Journey Medical Stock?
2026-09-21 16:02 · Yahoo
Journey Medical Corporation to Participate in September 2026 Investor Conferences
2026-09-08 20:05 · Yahoo
Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Labor
2026-08-31 09:05 · Yahoo
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
2026-08-25 15:20 · Yahoo
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
2026-08-19 21:58 · Yahoo
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ...
2026-08-13 05:02 · Yahoo
Journey Medical Q2 Earnings Call Highlights
2026-08-12 23:04 · Yahoo
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
2026-08-12 20:01 · Yahoo
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
2026-06-25 04:29 · Yahoo
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target
2026-06-03 22:07 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.